MosChip Shareholders Approve Director Appointments and Remuneration Revision
Moschip Technologies Limited shareholders approved the appointment of two Independent Directors, Mr. Sandeep Himmatlal Shah and Dr. Yellamanchali Sreenivas Rao, for five-year terms starting October 24, 2025. They also approved a revised remuneration for MD & CEO, Mr. Srinivasa Rao Kakumanu, effective January 1, 2026.
The appointment of independent directors and the revision of MD & CEO remuneration are significant corporate actions that can impact governance and management stability, but they do not represent immediate, substantial financial changes.
The company successfully passed all special resolutions with a significant majority, indicating shareholder confidence and support for the board's decisions regarding director appointments and executive remuneration.
Moschip Technologies Limited announced the outcome of its postal ballot and remote e-voting process, where shareholders approved three special resolutions.
The resolutions included the appointment of Mr. Sandeep Himmatlal Shah as an Independent Director for a five-year term effective October 24, 2025, and the appointment of Dr. Yellamanchali Sreenivas Rao as an Independent Director for a similar five-year term, also effective October 24, 2025.
Additionally, shareholders approved a revision in the terms of remuneration for Mr. Srinivasa Rao Kakumanu, the Managing Director & CEO. The revised remuneration package, effective from January 1, 2026, to March 31, 2027, includes a fixed annual pay of ₹3.06 crore and a variable annual pay of ₹54 lakh, subject to company performance.
The remote e-voting period concluded on January 20, 2026, and the scrutinizer's report confirmed that all three special resolutions were passed with the requisite majority. The company has uploaded this intimation on its website.
What to do with a filing like this
Moschip Technologies Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Moschip Technologies Limited. Read the original for the full detail.